Prostate Cancer - Results from #23460

Head-to-head comparison of prostate health index and urinary prostate cancer antigen 3 in predicting the presence of cancer at initial or repeat biopsy - Abstract April 11, 2013

An MRI-based dose-response analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial - Abstract April 11, 2013

Virginia Tech study finds virus promising for prostate cancer treatment April 11, 2013

A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: Quality of life outcomes after 36-month follow-up - Abstract April 11, 2013

Relationship between body mass index and serum testosterone concentration in patients receiving luteinizing hormone-releasing hormone agonist therapy for prostate cancer - Abstract April 11, 2013

Factors associated with reduction in use of neoadjuvant androgen suppression therapy before radical prostatectomy - Abstract April 11, 2013

Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate-specific antigen (PSA) testing by Dutch general practitioners - Abstract April 11, 2013

Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: A longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial - Abstract April 11, 2013

Simultaneous 18F choline positron emission tomography/tagnetic resonance imaging of the prostate: Initial results - Abstract April 11, 2013

The role of 1.5 Tesla magnetic resonance imaging in staging prostate cancer - Abstract April 11, 2013

Transrectal ultrasound based prostate volume determination: Is the frustum algorithm more accurate than planimetry? - Abstract April 11, 2013

A TCP model for external beam treatment of intermediate-risk prostate cancer - Abstract April 11, 2013

Prognostic Gleason grade grouping: Data based on the modified Gleason scoring system - Abstract April 11, 2013

Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy - Abstract April 11, 2013

Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance - Abstract April 11, 2013

Increased incidence of pathologically nonorgan confined prostate cancer in African-American men eligible for active surveillance - Abstract April 11, 2013

NIH grant focuses on nanotechnology to treat prostate cancer April 9, 2013

Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort - Abstract April 9, 2013

Repeat prostate biopsy strategies after initial negative biopsy: Meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy - Abstract April 9, 2013

Evolution of the concept of focal therapy for prostate cancer - Abstract April 9, 2013

Page 1174 of 1436